Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

[Targeted biopsies using magnetic resonance imaging/ultrasonograpgy fusion compared with sistematic biopsies prostate cancer detection. Initial experience.]

Bonet X, Suarez-Novo JF, Castells M, Serrallach M, Beato S, Picola N, Boladeras A, Ferrer F, Slocker A, Merino EM, García-Benet JR, Condom E, Hajianfar R, Heras L, Piulats JM, Vigués F.

Arch Esp Urol. 2020 Apr;73(3):192-201. Spanish.

PMID:
32240109
2.

Unusual case report of skin infection by Paenibacillus timonensis.

de Salazar A, Ferrer F, Vinuesa D, Chueca N, de Luis-Perez C, García F.

Rev Esp Quimioter. 2020 Apr;33(2):139-140. doi: 10.37201/req/079.2019. Epub 2020 Mar 9. No abstract available.

3.

EDITORIAL COMMENT.

Ferrer FA.

Urology. 2020 Mar;137:176-177. doi: 10.1016/j.urology.2019.11.055. No abstract available.

PMID:
32115064
4.

A simple and rapid liquid chromatography-mass spectrometry method to assay cabozantinib in plasma: Application to therapeutic drug monitoring in patients with renal cell carcinoma.

Ferrer F, Solas C, Giocanti M, Lacarelle B, Deville JL, Gravis G, Ciccolini J.

J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Feb 1;1138:121968. doi: 10.1016/j.jchromb.2020.121968. Epub 2020 Jan 7.

PMID:
31931326
5.

Local Control of Perineal Rhabdomyosarcoma: Are Current Recommendations Adequate?

Heermans JT, Makari JH, Ferrer FA Jr.

Urology. 2020 Mar;137:161-163. doi: 10.1016/j.urology.2019.11.011. Epub 2019 Nov 23.

PMID:
31770547
6.

Spanish validation of Charlson index applied to prostate cancer.

Casas Duran F, Valduvieco I, Oses G, Cortés KS, Barreto TD, Muñoz-Guglielmetti D, Ferrer F.

Clin Transl Oncol. 2019 Nov 20. doi: 10.1007/s12094-019-02246-0. [Epub ahead of print]

PMID:
31748962
7.

Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury.

Jang HS, Noh MR, Jung EM, Kim WY, Southekal S, Guda C, Foster KW, Oupicky D, Ferrer FA, Padanilam BJ.

Kidney Int. 2020 Feb;97(2):327-339. doi: 10.1016/j.kint.2019.08.019. Epub 2019 Sep 3.

PMID:
31733829
8.

Therapeutic anti-cancer activity of antibodies targeting sulfhydryl bond constrained epitopes on unglycosylated RON receptor tyrosine kinase.

Koh XY, Koh XH, Hwang LA, Ferrer FJ, Rahmat SAB, Lama D, Lane DP.

Oncogene. 2019 Nov;38(48):7342-7356. doi: 10.1038/s41388-019-0946-8. Epub 2019 Aug 15.

PMID:
31417186
9.

Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties.

Partridge AW, Kaan HYK, Juang YC, Sadruddin A, Lim S, Brown CJ, Ng S, Thean D, Ferrer F, Johannes C, Yuen TY, Kannan S, Aronica P, Tan YS, Pradhan MR, Verma CS, Hochman J, Chen S, Wan H, Ha S, Sherborne B, Lane DP, Sawyer TK.

Molecules. 2019 Jun 20;24(12). pii: E2292. doi: 10.3390/molecules24122292.

10.

Demographic and Parental Factors Associated With Developmental Outcomes in Children With Intellectual Disabilities.

Vilaseca R, Rivero M, Bersabé RM, Cantero MJ, Navarro-Pardo E, Valls-Vidal C, Ferrer F.

Front Psychol. 2019 Apr 24;10:872. doi: 10.3389/fpsyg.2019.00872. eCollection 2019.

11.

Spanish Validation of the PICCOLO (Parenting Interactions With Children: Checklist of Observations Linked to Outcomes).

Vilaseca R, Rivero M, Bersabé RM, Navarro-Pardo E, Cantero MJ, Ferrer F, Valls Vidal C, Innocenti MS, Roggman L.

Front Psychol. 2019 Mar 27;10:680. doi: 10.3389/fpsyg.2019.00680. eCollection 2019.

12.

Primordial Black Holes from the QCD Axion.

Ferrer F, Masso E, Panico G, Pujolas O, Rompineve F.

Phys Rev Lett. 2019 Mar 15;122(10):101301. doi: 10.1103/PhysRevLett.122.101301.

PMID:
30932654
13.

Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides.

Pal A, Neo K, Rajamani L, Ferrer FJ, Lane DP, Verma CS, Mortellaro A.

Sci Rep. 2019 Mar 20;9(1):4913. doi: 10.1038/s41598-019-41211-3.

14.

Comparison of two identification and susceptibility test kits for Ureaplasma spp and Mycoplasma hominis in amniotic fluid of patients at high risk for intra-amniotic infection.

Kusanovic JP, Vargas P, Ferrer F, Díaz F, Córdova V, Martinovic C, Valdés R, Rosas A, Luna D, Silva P, Silva K, Nilo ME, Silva MJ, Espejo E, Zambrano MA, García J, Parra-Lara LG, Escobar MF.

J Matern Fetal Neonatal Med. 2019 Feb 20:1-9. doi: 10.1080/14767058.2019.1572742. [Epub ahead of print]

PMID:
30786784
15.

Structural evidence for the roles of divalent cations in actin polymerization and activation of ATP hydrolysis.

Scipion CPM, Ghoshdastider U, Ferrer FJ, Yuen TY, Wongsantichon J, Robinson RC.

Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10345-10350. doi: 10.1073/pnas.1806394115. Epub 2018 Sep 25.

16.

Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.

Casas F, Valduvieco I, Oses G, Izquierdo L, Archila I, Costa M, Cortes KS, Barreto T, Ferrer F.

Clin Transl Oncol. 2019 Mar;21(3):355-362. doi: 10.1007/s12094-018-1931-3. Epub 2018 Aug 20.

PMID:
30128953
17.

Association between EBRT dose volume histograms and quality of life in prostate cancer patients.

Boladeras A, Ferrer F, Navarro V, De Blas R, Cunillera O, Mateo D, Gutierrez C, Martinez E, Villà S, Pera J, Ferrer M, Guedea F.

Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):360-368. doi: 10.1016/j.rpor.2018.07.009. Epub 2018 Aug 13.

18.

Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis.

Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M.

Cancer Treat Rev. 2018 May;66:23-44. doi: 10.1016/j.ctrv.2018.03.005. Epub 2018 Apr 3. Review.

PMID:
29673922
19.

Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.

Sawyer TK, Partridge AW, Kaan HYK, Juang YC, Lim S, Johannes C, Yuen TY, Verma C, Kannan S, Aronica P, Tan YS, Sherborne B, Ha S, Hochman J, Chen S, Surdi L, Peier A, Sauvagnat B, Dandliker PJ, Brown CJ, Ng S, Ferrer F, Lane DP.

Bioorg Med Chem. 2018 Jun 1;26(10):2807-2815. doi: 10.1016/j.bmc.2018.03.008. Epub 2018 Mar 16.

PMID:
29598901
20.

[Prostate cancer screening using prostate-specific antigen: The views of general and laboratory physicians].

Giménez N, Filella X, Gavagnach M, Allué JA, Pedrazas D, Ferrer F; Grupo de Estudio sobre Cribado en Cáncer de Próstata.

Semergen. 2018 Sep;44(6):409-419. doi: 10.1016/j.semerg.2018.02.001. Epub 2018 Mar 21. Spanish.

PMID:
29574008
21.

Cell-intrinsic sphingosine kinase 2 promotes macrophage polarization and renal inflammation in response to unilateral ureteral obstruction.

Ghosh M, Thangada S, Dasgupta O, Khanna KM, Yamase HT, Kashgarian M, Hla T, Shapiro LH, Ferrer FA.

PLoS One. 2018 Mar 8;13(3):e0194053. doi: 10.1371/journal.pone.0194053. eCollection 2018.

22.

Structure-activity studies of Mdm2/Mdm4-binding stapled peptides comprising non-natural amino acids.

Chee SMQ, Wongsantichon J, Siau J, Thean D, Ferrer F, Robinson RC, Lane DP, Brown CJ, Ghadessy FJ.

PLoS One. 2017 Dec 11;12(12):e0189379. doi: 10.1371/journal.pone.0189379. eCollection 2017.

23.

The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.

Wu HL, Wiseman RW, Hughes CM, Webb GM, Abdulhaqq SA, Bimber BN, Hammond KB, Reed JS, Gao L, Burwitz BJ, Greene JM, Ferrer F, Legasse AW, Axthelm MK, Park BS, Brackenridge S, Maness NJ, McMichael AJ, Picker LJ, O'Connor DH, Hansen SG, Sacha JB.

J Immunol. 2018 Jan 1;200(1):49-60. doi: 10.4049/jimmunol.1700841. Epub 2017 Nov 17.

24.

Epispadias repair with tunica vaginalis flap.

Zee RS, Makari JH, Ferrer F, Herndon CDA.

J Pediatr Urol. 2017 Oct;13(5):523-524. doi: 10.1016/j.jpurol.2017.05.023. Epub 2017 Jun 27.

PMID:
28689649
25.

Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery.

Thean D, Ebo JS, Luxton T, Lee XC, Yuen TY, Ferrer FJ, Johannes CW, Lane DP, Brown CJ.

Sci Rep. 2017 May 11;7(1):1763. doi: 10.1038/s41598-017-01712-5.

26.

Energy-Sensitive Ion- and Cathode-Luminescent Radiation-Beam Monitors Based on Multilayer Thin-Film Designs.

Gil-Rostra J, Ferrer FJ, Espinós JP, González-Elipe AR, Yubero F.

ACS Appl Mater Interfaces. 2017 May 17;9(19):16313-16320. doi: 10.1021/acsami.7b01175. Epub 2017 May 5.

PMID:
28436216
27.

Transabdominal collection of amniotic fluid "sludge" and identification of Candida albicans intra-amniotic infection.

Kusanovic JP, Romero R, Martinovic C, Silva K, Erez O, Maymon E, Díaz F, Ferrer F, Valdés R, Córdova V, Vargas P, Nilo ME, Le Cerf P.

J Matern Fetal Neonatal Med. 2018 May;31(10):1279-1284. doi: 10.1080/14767058.2017.1315095. Epub 2017 May 3.

28.

PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.

Caromile LA, Dortche K, Rahman MM, Grant CL, Stoddard C, Ferrer FA, Shapiro LH.

Sci Signal. 2017 Mar 14;10(470). pii: eaag3326. doi: 10.1126/scisignal.aag3326.

29.

Multicolored Emission and Lasing in DCM-Adamantane Plasma Nanocomposite Optical Films.

Alcaire M, Cerdán L, Zamarro FL, Aparicio FJ, González JC, Ferrer FJ, Borras A, Espinós JP, Barranco A.

ACS Appl Mater Interfaces. 2017 Mar 15;9(10):8948-8959. doi: 10.1021/acsami.7b01534. Epub 2017 Mar 2.

PMID:
28207230
30.

Bilateral Wilms Tumor With Ureteral Extension.

Lockwood G, Ferrer F, Makari J.

Urology. 2017 Apr;102:219-221. doi: 10.1016/j.urology.2016.12.046. Epub 2017 Jan 4.

PMID:
28063884
31.

Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.

Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.

Prostate. 2017 May;77(6):573-583. doi: 10.1002/pros.23295. Epub 2016 Dec 19.

PMID:
27990656
32.

Patterns of Performance of Oncologic Surgery by North American Pediatric Urologists: A Report from the Pediatric Urologic Oncology Working Group of the Society for Pediatric Urology.

Cost NG, Ross JH, Ferrer FA, Lorenzo AJ, Shnorhavorian M, Routh JC, Kieran K, Ritchey ML.

J Urol. 2017 May;197(5):1349-1354. doi: 10.1016/j.juro.2016.12.011. Epub 2016 Dec 13.

PMID:
27986529
33.

Characterization and Validation of a-Si Magnetron-Sputtered Thin Films as Solid He Targets with High Stability for Nuclear Reactions.

Godinho V, Ferrer FJ, Fernández B, Caballero-Hernández J, Gómez-Camacho J, Fernández A.

ACS Omega. 2016 Dec 14;1(6):1229-1238. doi: 10.1021/acsomega.6b00270. eCollection 2016 Dec 31.

34.

A Society for Pediatric Urology Workforce Survey on the Current Perceptions of Oncology Care by Pediatric Urologists: A Report from the Pediatric Urologic Oncology Working Group of the Society for Pediatric Urology.

Cost NG, Ferrer FA, Lorenzo AJ, Shnorhavorian M, Kieran K, Routh JC, Ritchey ML, Ross JH.

J Urol. 2017 Mar;197(3 Pt 2):892-897. doi: 10.1016/j.juro.2016.08.012. Epub 2016 Nov 9.

PMID:
27837647
35.

Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.

Fernandez CV, Perlman EJ, Mullen EA, Chi YY, Hamilton TE, Gow KW, Ferrer FA, Barnhart DC, Ehrlich PF, Khanna G, Kalapurakal JA, Bocking T, Huff V, Tian J, Geller JI, Grundy PE, Anderson JR, Dome JS, Shamberger RC.

Ann Surg. 2017 Apr;265(4):835-840. doi: 10.1097/SLA.0000000000001716.

36.

Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.

Casas F, Henríquez I, Bejar A, Maldonado X, Alvarez A, González-Sansegundo C, Boladeras A, Ferrer F, Hervás A, Herruzo I, Caro M, Rodriguez I, Ferrer C.

Clin Transl Oncol. 2017 Mar;19(3):373-378. doi: 10.1007/s12094-016-1538-5. Epub 2016 Oct 21.

PMID:
27770397
37.

Normal amino-terminal pro-brain natriuretic peptide (NT-proBNP) values in amniotic fluid.

Carvajal JA, Ferrer FA, Araya FI, Delpiano AM.

Clin Biochem. 2017 Jan;50(1-2):23-26. doi: 10.1016/j.clinbiochem.2016.09.002. Epub 2016 Sep 7.

PMID:
27614219
38.

Localized prostate cancer treated with external beam radiation therapy: Long-term outcomes at a European comprehensive cancer centre.

Boladeras A, Martinez E, Ferrer F, Gutierrez C, Villa S, Pera J, Guedea F.

Rep Pract Oncol Radiother. 2016 May-Jun;21(3):181-7. doi: 10.1016/j.rpor.2015.12.002. Epub 2016 Feb 20.

39.

Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

Murcia L, Carrilero B, Ferrer F, Roig M, Franco F, Segovia M.

Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1819-1827. Epub 2016 Aug 4.

PMID:
27488437
40.

Surgical protocol violations in children with renal tumors provides an opportunity to improve pediatric cancer care: a report from the Children's Oncology Group.

Ehrlich PF, Hamilton TE, Gow K, Barnhart D, Ferrer F, Kandel J, Glick R, Dasgupta R, Naranjo A, He Y, Perlman EJ, Kalapurakal JA, Khanna G, Dome JS, Geller J, Mullen E.

Pediatr Blood Cancer. 2016 Nov;63(11):1905-10. doi: 10.1002/pbc.26083. Epub 2016 May 27.

41.

Focusing on organ preservation and function: paradigm shifts in the treatment of pediatric genitourinary rhabdomyosarcoma.

Shapiro DD, Harel M, Ferrer F, McKenna PH.

Int Urol Nephrol. 2016 Jul;48(7):1009-13. doi: 10.1007/s11255-016-1285-0. Epub 2016 Apr 11. Review.

PMID:
27068815
42.

The successes, failures, advantages and limitations of the cooperative oncology study groups in pediatric urologic oncology.

Ferrer F.

Urol Oncol. 2016 Feb;34(2):63-4. doi: 10.1016/j.urolonc.2015.11.002. Epub 2015 Dec 17. Review. No abstract available.

PMID:
26706118
43.

Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.

Gerber C, Harel M, Lynch ML, Herbst KW, Ferrer FA, Shapiro LH.

J Pediatr Urol. 2016 Apr;12(2):120.e1-7. doi: 10.1016/j.jpurol.2015.10.008. Epub 2015 Nov 28.

PMID:
26705690
44.

Search for GeV γ-Ray Pair Halos Around Low Redshift Blazars.

Chen W, Buckley JH, Ferrer F.

Phys Rev Lett. 2015 Nov 20;115(21):211103. doi: 10.1103/PhysRevLett.115.211103. Epub 2015 Nov 16.

PMID:
26636838
45.

Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.

Harel M, Ferrer FA, Shapiro LH, Makari JH.

Urol Oncol. 2016 Feb;34(2):103-15. doi: 10.1016/j.urolonc.2015.09.013. Epub 2015 Oct 28. Review.

PMID:
26519985
46.

Overhydration prevalence in peritoneal dialysis - A 2 year longitudinal analysis.

Aguiar PV, Santos O, Teixeira L, Silva F, Azevedo P, Vidinha J, Ferrer F, Carvalho MJ, Cabrita A, Rodrigues A.

Nefrologia. 2015;35(2):189-96. doi: 10.1016/j.nefro.2015.05.020. Epub 2015 Jun 23.

48.

Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays.

Tan BX, Brown CJ, Ferrer FJ, Yuen TY, Quah ST, Chan BH, Jansson AE, Teo HL, Nordlund P, Lane DP.

Sci Rep. 2015 Jul 10;5:12116. doi: 10.1038/srep12116.

49.

Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.

Li MH, Swenson R, Harel M, Jana S, Stolarzewicz E, Hla T, Shapiro LH, Ferrer F.

J Pharmacol Exp Ther. 2015 Sep;354(3):261-8. doi: 10.1124/jpet.115.224519. Epub 2015 Jun 23.

50.

Objective pain assessment after ureteral reimplantation: comparison of open versus robotic approach.

Harel M, Herbst KW, Silvis R, Makari JH, Ferrer FA, Kim C.

J Pediatr Urol. 2015 Apr;11(2):82.e1-8. doi: 10.1016/j.jpurol.2014.12.007. Epub 2015 Feb 26.

PMID:
25864615

Supplemental Content

Loading ...
Support Center